677
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A Global Pandemic and Substance Use Disorder: Healthcare Professionals’ Viewpoints on the Merging of Two Crises

, , &

References

  • Blanco, C., Compton, W. M., & Volkow, N. D. (2021). Opportunities for research on the treatment of substance use disorders in the context of COVID-19. JAMA Psychiatry, 78(4), 357. https://doi.org/10.1001/jamapsychiatry.2020.3177
  • Chiappini, S., Guirguis, A., John, A., Corkery, J. M., & Schifano, F. (2020). COVID-19: The hidden impact on mental health and drug addiction. Frontiers in Psychiatry, 11, 767. https://doi.org/10.3389/fpsyt.2020.00767
  • Courser, M. W., & Raffle, H. (2021). With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 122, 108220. https://doi.org/10.1016/j.jsat.2020.108220
  • Creswell, J. W., & Creswell, J. D. (2018). Research design: Qualitative, quantitative, and mixed methods approaches (5th ed.). SAGE Publications, Inc.
  • Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., Hart, C., Kerr, T., Lajous, A. M., Lewis, S., Martin, N., Mejía, D., Camacho, A., Mathieson, D., Obot, I., Ogunrombi, A., Sherman, S., Stone, J., Vallath, N., Vickerman, P., Zábranský, T., & Beyrer, C. (2016). Public health and international drug policy. The Lancet, 387(10026), 1427–1480. https://doi.org/10.1016/S0140-6736(16)00619-X
  • Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G., Ryan, J., Hall, M., Ezard, N., Haber, P., Lintzeris, N., & Maher, L. (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(1), 26. https://doi.org/10.1186/s12954-020-00370-7
  • Friedman, J., Beletsky, L., & Schriger, D. L. (2021). Overdose-related cardiac arrests observed by emergency medical services during the US COVID-19 epidemic. JAMA Psychiatry, 78(5), 562. https://doi.org/10.1001/jamapsychiatry.2020.4218
  • Genberg, B. L., Astemborski, J., Piggott, D. A., Woodson-Adu, T., Kirk, G. D., & Mehta, S. H. (2021). The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland. Drug and Alcohol Dependence, 221, 108584. https://doi.org/10.1016/j.drugalcdep.2021.108584
  • Goldman, A. W. (2018). How much would eliminating drug crimes decrease racial/ethnic gaps in criminal conviction?Social Science Research, 76, 65–76. https://doi.org/10.1016/j.ssresearch.2018.07.005
  • Holland, K. M., Jones, C., Vivolo-Kantor, A. M., Idaikkadar, N., Zwald, M., Hoots, B., Yard, E., D’Inverno, A., Swedo, E., Chen, M. S., Petrosky, E., Board, A., Martinez, P., Stone, D. M., Law, R., Coletta, M. A., Adjemian, J., Thomas, C., Puddy, R. W., Peacock, G., Dowling, N. F., & Houry, D. (2021). Trends in US Emergency Department Visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiatry, 78(4), 372. https://doi.org/10.1001/jamapsychiatry.2020.4402
  • Jemberie, W. B., Stewart Williams, J., Eriksson, M., Gronlund, A. S., Ng, N., Blom Nilsson, M., Padyab, M., Priest, K. C., Sandlund, M., Snellman, F., McCarty, D., & Lundgren, L. M. (2020). Substance use disorders and COVID-19: Multi-faceted problems which require multi-pronged solutions. Frontiers in Psychiatry, 11, 714. https://doi.org/10.3389/fpsyt.2020.00714
  • Johnson, K., Rigg, K. K., & Hopkins Eyles, C. (2020). Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter?International Journal on Drug Policy, 75, 102583. https://doi.org/10.1016/j.drugpo.2019.10.009
  • Jones, C. M., Guy, G. P., Jr., & Board, A. (2021). Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020. Drug and Alcohol Dependence., 219, 108486. https://doi.org/10.1016/j.drugalcdep.2020.108486
  • Khatri, U. G., Pizzicato, L. N., Viner, K., Bobyock, E., Sun, M., Meisel, Z. F., & South, E. C. (2021). Racial/Ethnic disparities in unintentional fatal and nonfatal emergency medical services-attended opioid overdoses during the COVID-19 pandemic in Philadelphia. JAMA Network Open, 4(1), e2034878. https://doi.org/10.1001/jamanetworkopen.2020.34878
  • Kuehn, B. M. (2021). Accelerated overdose deaths linked with COVID-19. JAMA, 325(6), 523. https://doi.org/10.1001/jama.2021.0074
  • LeSaint, K., & Snyder, H. R. (2020). Impact of social distancing on individuals who use drugs: considerations for emergency department providers. Western Journal of Emergency Medicine, 21(5):1102–1104. https://doi.org/10.5811/westjem.2020.7.47896
  • Linas, B. P., Savinkina, A., Barbosa, C., Mueller, P. P., Cerdá, M., Keyes, K., & Chhatwal, J. (2021). A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose. Journal of Substance Abuse Treatment, 120, 108158. https://doi.org/10.1016/j.jsat.2020.108158
  • Lopez-Pelayo, H., Aubin, H. J., Drummond, C., Dom, G., Pascual, F., Rehm, J., Saitz, R., Scafato, E., & Gual, A. (2020). “The post-COVID era”: Challenges in the treatment of substance use disorder (SUD) after the pandemic. BMC Medicine, 18(1), 241. https://doi.org/10.1186/s12916-020-01693-9
  • Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook (2nd ed.). Sage Publications, Inc.
  • Patton, M. Q. (2015). Qualitative research & evaluation methods: Integrating theory and practice (4th ed.). Sage Publications, Inc.
  • Stack, E., Leichtling, G., Larsen, J. E., Gray, M., Pope, J., Leahy, J. M., Gelberg, L., Seaman, A., & Korthuis, P. T. (2020). The impacts of COVID-19 on mental health, substance use, and overdose concerns of people who use drugs in rural communities. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000770
  • Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019). Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Medicine, 16(11), e1002969. https://doi.org/10.1371/journal.pmed.1002969

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.